Julie Zang is a Dermatology physician affiliated with Rockefeller University. OpenAlex indexes 8 publications with 2,098 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3808 Union St
Ste 3f
Flushing, NY 113545544
Telephone
646-872-7148Registry record last updated 15 Apr 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- MERZ NORTH AMERICA, INC.Program year20253 payments
- Galderma Laboratories, L.P.Program year20241 payment
- Galderma Laboratories, L.P.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
27.5%Corticosteroid15.7%Triamcinolone Acetonide92%Halobetasol Propionate8%Part D≥168 patientsalpha-Hydroxy Acid3.8%Ammonium Lactate100%Part D≥40 patients+ 5 more classes in this area
Anti-infectives
22.6%Azole Antifungal11%Ketoconazole100%Part D≥73 patientsLincosamide Antibacterial3.3%Clindamycin Phosphate100%Part D≥37 patients+ 4 more classes in this area
Respiratory
19%RNA Synthetase Inhibitor Antibacterial15.3%Mupirocin100%Part D≥203 patientsHistamine-1 Receptor Antagonist1.9%Levocetirizine Dihydrochloride100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Identification of Loss of Specific FMRP-RNA Interactions as a Cause of Fragile X Syndrome
Digital Commons - RU (Rockefeller University)
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Athanasios Dousmanis, MD
Rockefeller University
Jan Breslow, MD
Rockefeller University
Rhonda Kost, MD
Rockefeller University
Charlie Buffie, MD, PhD
Rockefeller University
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”